10-Q: OSI Systems Reports Q3 FY26 Results, Revenue Up 2%

OSI Systems, Inc. announced its financial results for the third quarter of fiscal year 2026, reporting a 2.0% increase in total net revenues to $453.2 million.

Summary

• OSI Systems reported total net revenues of $453.2 million for the third quarter of fiscal year 2026, an increase of 2.0% compared to $444.3 million in the same period last year.
• The Security division saw a 1.4% revenue increase to $319.2 million, driven by service revenues.
• The Optoelectronics and Manufacturing division experienced an 8.9% revenue increase to $93.3 million, attributed to growth in contract manufacturing.
• The Healthcare division's revenue decreased by 6.9% to $40.7 million, mainly due to lower patient monitoring sales and service.
• Gross profit remained stable at $150.3 million, but the gross margin slightly decreased to 33.2% from 33.8% due to a less favorable revenue mix.
• Operating expenses increased by 3.3% to $97.2 million, largely due to higher impairment, restructuring, and other charges, which more than doubled to $6.2 million.
• Interest and other expense, net, significantly decreased by 51.2% to $4.0 million, primarily due to lower average interest rates and higher interest income.
• Net income for the quarter was $40.2 million, a slight decrease from $41.1 million in the prior year period.
• Diluted earnings per share were $2.33, down from $2.40 in the prior year.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, with revenue growth and strong liquidity offset by margin pressure and increased restructuring costs.

Positives

• Total net revenues increased by 2.0% to $453.2 million.
• Security division revenue grew by 1.4% to $319.2 million, supported by increased service revenues.
• Optoelectronics and Manufacturing division revenue increased by 8.9% to $93.3 million, driven by contract manufacturing growth.
• Significant reduction in interest and other expense, net, by 51.2% to $4.0 million, due to lower interest rates and higher interest income.
• Cash and cash equivalents increased substantially to $345.2 million as of March 31, 2026, from $106.4 million at June 30, 2025.
• Net cash provided by financing activities was $174.1 million for the nine months ended March 31, 2026, primarily due to the issuance of convertible notes.

Negatives

• Healthcare division revenue decreased by 6.9% to $40.7 million.
• Gross margin decreased to 33.2% from 33.8% due to a less favorable revenue mix.
• Impairment, restructuring and other charges increased significantly by 169.6% to $6.2 million.
• Net income decreased slightly to $40.2 million from $41.1 million.
• Diluted earnings per share decreased to $2.33 from $2.40.
• Cash provided by operating activities decreased to $93.8 million from $97.0 million for the nine-month period.
• Unbilled revenue (contract asset) decreased by 28.0% to $174.8 million.

Risks

• Global macroeconomic factors, including supply chain environment, inflationary pressure, interest rates, and labor shortages, create uncertainty and could impact demand.
• Increasing diplomatic and trade friction, including sanctions, international political unrest, and volatile U.S. political climate, could adversely affect business.
• Tariffs and trade restrictions could result in revenue reductions or cost increases.
• Continued constraints in the supply of memory and semiconductor components could adversely affect the business.
• Hospitals facing financial pressure due to supply chain constraints and inflation may reduce capital equipment spending.
• Changes in U.S. or foreign government legislative, regulatory, or enforcement policies, including potential government shutdowns, could materially affect results.
• Ongoing military conflicts and geopolitical tensions in the Middle East may adversely affect global markets, supply chains, and customer demand.
• Potential for malicious cyber-activity from state and non-state actors.
• Delays in customer acceptance could impact revenue recognition.
• Unfavorable currency exchange rate fluctuations could impact sales.
• The company is subject to various environmental laws and regulations, and unfavorable outcomes could be material.

Future Outlook

The company anticipates that its available funds, credit facilities, and cash flow from operations will be sufficient to meet its operational cash needs for the next 12 months and the foreseeable future. The company expects to recognize revenue on approximately 37% of its remaining performance obligations ($877.2 million as of March 31, 2026) over the next 12 months.

Management Comments

• "Throughout our journey together, we have dedicated ourselves to building an organization that makes a positive impact on the world, by making it safer and healthier. The foundation of our ongoing achievements is our commitment to upholding a solid reputation and preserving the trust of those we serve - customers, investors, and the broader community. This is only possible when we consistently embody our core values of Integrity, Accountability, Innovation, and Teamwork."
• "Our customers, shareholders, and colleagues depend on us to do the right thing - every time."
• "The Code of Ethics and Conduct outlines the standards for our behavior in every aspect of our work."
• "We are committed to operating according to the highest ethical standards and in full compliance with applicable laws and regulations."
• "We expect you to Speak Up by raising issues and reporting any instances where you see or suspect a breach of this Code or have concerns about the way in which we are doing business."
• "Our company maintains a zero-tolerance policy towards fraud in any form."
• "We are firmly committed to complying with international anti-corruption and anti-bribery laws including the U.S. Foreign Corrupt Practices Act (FCPA) and the U.K. Bribery Act."

Industry Context

StockSavvy.ai notes that OSI Systems operates in diverse markets including homeland security, healthcare, defense, and aerospace. The company's performance is influenced by global economic conditions, government spending, and technological advancements in these sectors. The reported revenue growth, particularly in the Security and Optoelectronics divisions, aligns with ongoing demand for advanced screening and specialized electronic components, while the decline in Healthcare revenue reflects broader industry pressures on hospital capital spending.

Comparison to Industry Standards

• The gross margin of 33.2% for the quarter is within the typical range for diversified industrial and technology companies, though specific comparisons depend on the sub-sectors within Security, Optoelectronics, and Healthcare.
• The increase in R&D spending as a percentage of revenue (4.3% in Q3 FY26) is consistent with companies investing in innovation for specialized electronic systems and components.
• The significant increase in impairment, restructuring, and other charges ($6.2 million) warrants attention, as it is higher than the prior year's $2.3 million and suggests ongoing integration or efficiency efforts, which can vary across industries.
• The substantial increase in cash and cash equivalents to $345.2 million provides strong liquidity, exceeding many industry benchmarks for companies of similar size and operational scope.

Corporate Governance

Legal Proceedings

• The company is involved in potential or actual claims, litigation, and other legal proceedings arising in the ordinary course of business. Management believes the ultimate disposition of these proceedings is not likely to have a material adverse effect on the business, financial condition, results of operations, or cash flows.

Stakeholder Impact

• Shareholders: Slight decrease in net income and EPS, but strong liquidity and revenue growth in key segments provide a stable outlook.
• Employees: Increased R&D compensation costs suggest continued investment in talent for new product development; restructuring charges may impact some employees.
• Customers: Continued provision of security and specialized electronic systems; potential impact on healthcare customers due to financial pressures.
• Suppliers: Potential for increased costs due to supply chain constraints and tariffs; company is taking measures to contain these costs.
• Creditors: Company has significant debt, including convertible notes, but maintains strong liquidity and access to credit facilities.

Next Steps

• Continue to monitor global economic and geopolitical factors that could impact demand and operations.
• Manage supply chain risks for memory and semiconductor components.
• Integrate acquired businesses and manage restructuring initiatives.
• Recognize revenue from remaining performance obligations over the next 12 months and beyond.
• Evaluate the financial impact of the 'One Big Beautiful Bill Act' (OBBBA) on tax liabilities and deferred tax balances.

Key Dates

Recommendation

The company demonstrates steady revenue growth in key segments and maintains strong liquidity. However, margin pressures, increased restructuring costs, and ongoing global economic uncertainties warrant a cautious approach. The slight decrease in net income and EPS, while expected, does not provide a strong catalyst for a buy rating at this time. A 'hold' recommendation reflects the balance of positive operational execution against persistent external risks and internal cost pressures.

Keywords

OSI Systems, 10-Q, Quarterly Report, Security Systems, Optoelectronics, Healthcare Technology, Financial Results, Revenue, Net Income, Earnings Per Share, Convertible Notes, Credit Facility